资讯

Damage to the body’s organs from lupus, an autoimmune disorder caused by a patient’s own immune system attacking healthy tissues, can result in a wide range of symptoms, from skin issues to kidney and ...
Lupus can affect patients in many ways, and although no two patients will share exactly the same symptoms, there are some common symptoms that most people know of, like a butterfly rash, joint pain, ...
Like any relationship, a patient-doctor one has rules about how to engage and communicate. They’re typically in writing, bearing the patient’s signature of agreement. I’ve seen the rules posted on ...
Depression and anxiety are more likely in people with systemic lupus erythematosus (SLE) who also are at a greater risk of heart disease, like those with obesity or high blood pressure, a study ...
Pain wakes me at 3:18 a.m., reminding me that lupus stopped me from working. “Yeah, I know,” I sleep-whisper and stare at the digital clock until box breathing cools me back to sleep. An hour later, 4 ...
Despite what you’ve read, there is no established diet for lupus. There are certain foods that may improve life while living with lupus, and that are certain foods that can worsen your flares and how ...
We’ve heard it said that “you can’t pour from an empty cup.” It’s a reminder to “fill” ourselves before we “pour out” for someone else. Pouring out is an action we do to improve someone else’s life.
Lupus is an autoimmune disorder wherein the immune system attacks the body’s own healthy tissue. A diagnosis can be challenging as there is no single, definite test available. Furthermore, lupus ...
Air pollution was strongly linked to disease activity in children and adolescents with systemic lupus erythematosus (SLE) in the study, “Air pollution exposure may worsen lupus in children,” presented ...
PALIZADE, a Phase 2b clinical trial of Kezar Life Sciences’ investigational therapy zetomipzomib, is still enrolling systemic lupus erythematosus (SLE) patients with active lupus nephritis, a severe ...
The U.S. Food and Drug Administration (FDA) has agreed to allow Kyverna Therapeutics to begin clinical testing of KYV-101, the company’s investigational cell therapy for lupus nephritis, a form of ...